Literature DB >> 18786527

Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.

Akira Takahara1, Yuji Nakamura, Atsushi Sugiyama.   

Abstract

Bepridil and amiodarone are known to have a multiple ion channel-blocking property in the heart. In this study, we compared the effects of bepridil on beat-to-beat variability of repolarization, a new predictive marker of torsades de pointes arrhythmia, with those of amiodarone. Bepridil (30 mg/kg, n=4) or amiodarone (200 mg/day for initial 7 days and 100 mg/day for following 21 days, n=4) was orally administered to chronic atrioventricular block dogs under the Holter ECG monitoring. The QT interval was prolonged after the administration of bepridil and amiodarone, and torsades de pointes arrhythmia was induced in 3 out of 4 dogs after the bepridil administration, which was not observed during the chronic administration of amiodarone. Beat-to-beat variability of repolarization, quantified as the short-term variability of the QT interval, increased after the administration of bepridil by +3.0 ms, whereas no significant change was detected in this parameter after the administration of amiodarone. These results suggest that the beat-to-beat variability of repolarization is a useful marker for differentiating the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786527     DOI: 10.1016/j.ejphar.2008.08.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Relation between beat-to-beat QT interval variability and T-wave amplitude in healthy subjects.

Authors:  Muhammad A Hasan; Derek Abbott; Mathias Baumert
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

3.  Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.

Authors:  L Nalos; R Varkevisser; M K B Jonsson; M J C Houtman; J D Beekman; R van der Nagel; M B Thomsen; G Duker; P Sartipy; T P de Boer; M Peschar; M B Rook; T A B van Veen; M A G van der Heyden; M A Vos
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.

Authors:  A Takahara; Y Nakamura; H Wagatsuma; S Aritomi; A Nakayama; Y Satoh; Y Akie; A Sugiyama
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

5.  Bepridil, a class IV antiarrhythmic agent, can block the TREK-1 potassium channel.

Authors:  Ying Wang; Zhijie Fu; Zhiyong Ma; Na Li; Hong Shang
Journal:  Ann Transl Med       Date:  2021-07

6.  One-Pot Route from Halogenated Amides to Piperidines and Pyrrolidines.

Authors:  Qiao Song; Sheng Wang; Xiangui Lei; Yan Liu; Xin Wen; Zhouyu Wang
Journal:  Molecules       Date:  2022-07-22       Impact factor: 4.927

Review 7.  The canine chronic atrioventricular block model in cardiovascular preclinical drug research.

Authors:  Vera Loen; Marc A Vos; Marcel A G van der Heyden
Journal:  Br J Pharmacol       Date:  2021-05-04       Impact factor: 9.473

8.  Negative lusitropic property of nifekalant identified using ventricular pressure-volume loop analyses in anesthetized monkeys.

Authors:  Tomomichi Ishizaka; Yu Yoshimatsu; Yu Maeda; Katsuyoshi Chiba; Kazuhiko Mori
Journal:  Exp Anim       Date:  2018-10-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.